Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2011, Article ID 237638, 5 pages
http://dx.doi.org/10.1155/2011/237638
Research Article

Serum Amyloid Alpha in Parapneumonic Effusions

1Respiratory Department, University Hospital of Larissa, Biopolis, 41110 Larissa, Greece
2“Sismanoglio” General Hospital of Attica, 15126 Athens, Greece
3Intensive Care Unit, University Hospital of Thessaly, Biopolis, 41110 Larissa, Greece
4Respiratory Department, Chania General Hospital, 73300 Chania, Greece

Received 5 June 2011; Accepted 16 June 2011

Academic Editor: Dennis Daniel Taub

Copyright © 2011 Vagelis Boultadakis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. A. Maskell, S. Batt, E. L. Hedley, C. W. H. Davies, S. H. Gillespie, and R. J. O. Davies, “The bacteriology of pleural infection by genetic and standard methods and its mortality significance,” American Journal of Respiratory and Critical Care Medicine, vol. 174, no. 7, pp. 817–823, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. N. M. Rahman, S. J. Chapman, and R. J. O. Davies, “The approach to the patient with a parapneumonic effusion,” Clinics in Chest Medicine, vol. 27, no. 2, pp. 253–266, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Ozol, S. Oktem, and E. Erdinc, “Complicated parapneumonic effusion and empyema thoracis: microbiologic and therapeutic aspects,” Respiratory Medicine, vol. 100, no. 2, pp. 286–291, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Jiménez, G. Díaz, S. García-Rull, R. Vidal, A. Sueiro, and R. W. Light, “Routine use of pleural fluid cultures. Are they indicated?. Limited yield, minimal impact on treatment decisions,” Respiratory Medicine, vol. 100, no. 11, pp. 2048–2052, 2006. View at Publisher · View at Google Scholar
  5. R. W. Light, “A new classification of parapneumonic effusions and empyema,” Chest, vol. 108, no. 2, pp. 299–301, 1995. View at Google Scholar · View at Scopus
  6. C. Alemán, J. Alegre, J. Monasterio et al., “Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions,” Clinical Science, vol. 105, no. 5, pp. 601–607, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. F. C. Lin, Y. C. Chen, F. J. Chen, and S. C. Chang, “Cytokines and fibrinolytic enzymes in tuberculous and parapneumonic effusions,” Clinical Immunology, vol. 116, no. 2, pp. 166–173, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. G. E. Utine, U. Ozcelik, E. Yalcin et al., “Childhood parapneumonic effusions: biochemical and inflammatory markers,” Chest, vol. 128, no. 3, pp. 1436–1441, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. Porcel, M. Vives, and A. Esquerda, “Tumor necrosis factor-α in pleural fluid: a marker of complicated parapneumonic effusions,” Chest, vol. 125, no. 1, pp. 160–164, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. A. M. Okino, C. Bürger, J. R. Cardoso, E. L. Lavado, P. A. Lotufo, and A. Campa, “The acute-phase proteins serum amyloid A and C reactive protein in transudates and exudates,” Mediators of Inflammation, vol. 2006, Article ID 47297, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. K. T. Lewis and D. A. Bukstein, “Parapneumonic empyema in children: diagnosis and management,” American Family Physician, vol. 46, no. 5, pp. 1443–1458, 1992. View at Google Scholar · View at Scopus
  12. R. E. Bryant and C. J. Salmon, “Pleural effusion and empyema,” in Principles and Practice of Infectious Diseases, G. L. Mandell, R. Dolin, and J. E. Bennett, Eds., pp. 743–750, Churchill Livingstone, Philadelphia, Pa, USA, 2000. View at Google Scholar
  13. C. W. Davies, F. V. Gleeson, and R. J. Davies, “Pleural diseases group, standards of care committee, british thoracic society,” Thorax, vol. 58, supplement II, pp. ii18–ii28, 2003. View at Google Scholar
  14. C. Gabay and I. Kushner, “Acute-phase proteins and other systemic responses to inflammation,” New England Journal of Medicine, vol. 340, no. 6, pp. 448–454, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Upragarin, W. J. M. Landman, W. Gaastra, and E. Gruys, “Extrahepatic production of acute phase serum amyloid A,” Histology and Histopathology, vol. 20, no. 4, pp. 1295–1307, 2005. View at Google Scholar · View at Scopus
  16. J. V. Castell, M. J. Gomez-Lechon, M. David, R. Fabra, R. Trullenque, and P. C. Heinrich, “Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6,” Hepatology, vol. 12, no. 5, pp. 1179–1186, 1990. View at Publisher · View at Google Scholar · View at Scopus
  17. S. L. Silverman, E. S. Cathcart, M. Skinner, and A. S. Cohen, “The degradation of serum amyloid A protein by activated polymorphonuclear leucocytes: participation of granulocytic elastase,” Immunology, vol. 46, no. 4, pp. 737–744, 1982. View at Google Scholar · View at Scopus
  18. E. Sapey and R. A. Stockley, “COPD exacerbations·2: aetiology,” Thorax, vol. 61, no. 3, pp. 250–258, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. S. M. Opal and V. A. DePalo, “Anti-inflammatory cytokines,” Chest, vol. 117, no. 4, pp. 1162–1172, 2000. View at Google Scholar · View at Scopus
  20. A. Yokoyama, N. Kohno, S. Fujino, M. Abe, O. Ishida, and K. Hiwada, “Soluble interleukin-6 receptor levels in pleural effusions,” Respiratory Medicine, vol. 90, no. 6, pp. 329–332, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. C. A. Dinarello, “Interleukin-1: amino acid sequences, multiple biological activities and comparison with tumor necrosis factor (cachectin),” The Year in Immunology, vol. 2, pp. 68–89, 1986. View at Google Scholar · View at Scopus
  22. C. Silva-Mejias, F. Gamboa-Antinolo, L. F. Lopez-Cortez, M. Cruz-Ruiz, and J. Pachon, “Interleukin-1β in pleural fluids of different etiologies: its role as inflammatory mediator in empyema,” Chest, vol. 108, no. 4, pp. 942–945, 1995. View at Google Scholar · View at Scopus
  23. K. Shimokata, H. Saka, T. Murate, Y. Hasegawa, and T. Hasegawa, “Cytokine content in pleural effusion: comparison between tuberculous and carcinomatous pleurisy,” Chest, vol. 99, no. 5, pp. 1103–1107, 1991. View at Google Scholar · View at Scopus
  24. British Thoracic Society Standards of Care Committee, “BTS guidelines for the management of community acquired pneumonia in adults,” Thorax, vol. 56, supplement 4, pp. IV1–64, 2001. View at Google Scholar